Point72 Asset Management L.P. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management L.P. | 8,647 0.200% |
-176,719 (-95.34%) |
Filing |
| 2022-02-14 4:28 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management L.P. | 185,366 5.200% |
2,645 (+1.45%) |
Filing |
| 2021-12-21 5:13 pm Purchase |
2021-12-20 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management L.P. | 182,721 5.200% |
182,721 (New Position) |
Filing |